| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/27/2000 | WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 07/27/2000 | WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | WO2000023086A3 Buffered compositions for dialysis |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | DE19902590A1 Removal of ethyl 3-dimethylamino-2-phenylpropionate from ethyl 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylate solution comprises treatment with carboxylic acid |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359633A1 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2359096A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358474A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021444A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS |
| 07/26/2000 | EP1021188A1 Inhibitors of prenyl-protein transferase |
| 07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1260990A Licopin preparation for treating prostatic diseases and preparing process thereof |
| 07/26/2000 | CN1054850C Piperazine compounds used in therapy |
| 07/26/2000 | CN1054764C Zhuieng tougu plaster for dissipating wind and removing dampness |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor |
| 07/25/2000 | CA2205285C Benzoic acid derivative and pharmaceutical composition |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042042A2 High affinity inhibitors for target validation and uses thereof |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042013A1 Cinnamamide derivatives and drug compositions containing the same |
| 07/20/2000 | WO2000042011A1 Amide compounds |
| 07/20/2000 | WO2000041728A1 Compositions for treating frequent urination and urinary incontinence |
| 07/20/2000 | WO2000041713A2 Composition and method for improving function of embryonic kidney transplants |
| 07/20/2000 | WO2000041705A1 Pre-conditioning against cell death |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/20/2000 | CA2361924A1 Compositions for treating frequent urination and urinary incontinence |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2360268A1 Pre-conditioning against cell death |
| 07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356990A1 Composition and method for improving function of embryonic kidney transplants |
| 07/20/2000 | CA2352509A1 Cinnamamide derivatives and pharmaceutical compositions containing the same |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/19/2000 | EP1020190A2 Treatment of BPH with cGMP elevators |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019369A1 Thio derivatives as naaladase inhibitors |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019358A1 Novel compounds, their use and preparation |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019063A1 Modulation of immune responses |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019055A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
| 07/19/2000 | EP1019048A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | CN1260794A 5-aryl-3-(8-azabicyclo (3.2.2) oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as -5HT4 receptor ligands |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260209A Medicine for nephritis--Shenyanling |
| 07/19/2000 | CN1260202A Medicament for treating urinary calculus and its preparation method |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/18/2000 | US6090945 Tetrahydro-beta-carbolines |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090410 Dry mix formulation for bisphosphonic acids |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2117610C Indole derivatives as steroid 5 alpha-reductase inhibitors |